Biomarkers from Discovery to Clinical Diagnostics Applications of Single-Molecule Array (Simoa) Technology

Video   Mar 17, 2015

 


About the Speaker
Andreas Jeromin, PhD, has established research programs in translational neuroscience in both industry and biotech for the last 15 years and co-authored more than 100 publications. He has also been elected a member of the Dana Alliance for Brain Initiatives. Andreas Jeromin has led biomarker qualification programs in diagnostics and therapeutics in acute neurological injury and neurodegeneration in roles with increased responsibilities. This included several drug development program from POC to a NINDS-supported phase III trial (Protect III). He also supports as member of the SABs or steering committee, several biomarker qualification efforts such as ADNI, the Coalition against Major Diseases (CAMD) directed by the Critical Path Institute (C-PATH), the Alzheimer's Association CSF QC and biomarker assay standardization initiatives in other CNS disorders, including MS (Accelerated Cure), ALS and PD. He is the founder and CSO of Atlantic Biomarkers, LLC, and joined Quanterix, Inc. as scientific and medical advisor in 2014.

 
 
 
 

Recommended Videos

Company Incorporates Pregnancy Test into Magazine Advert

Video

Mercene Labs has developed a very large pregnancy test integrated in a printed advertisement for IKEA. The finished ad appeared in the Swedish women’s magazine Amelia.

WATCH NOW

Biggest Science News Stories of 2017

Video

We have seen some amazing scientific breakthroughs in 2017, here is a selection of our favourites.

WATCH NOW

The Woman Who Can Smell Parkinson's Disease

Video

Joy Milne has an incredible sense of smell that is able to recognise Parkinson's disease on the human body.

WATCH NOW

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE